Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,700.00 at Citigroup

Mettler-Toledo International (NYSE:MTD) had its target price hoisted by Citigroup from $1,600.00 to $1,700.00 in a research report released on Monday morning,Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock.

Other equities research analysts have also issued reports about the stock. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday. Bank of America upped their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. JPMorgan Chase & Co. increased their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Stifel Nicolaus boosted their price target on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday. Finally, Barclays upped their price target on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research report on Monday. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,433.54 on Monday. The business has a 50-day moving average of $1,323.11 and a 200 day moving average of $1,240.69. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,454.68. The stock has a market capitalization of $29.53 billion, a PE ratio of 36.30, a P/E/G ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,527 shares of company stock worth $1,994,981 over the last three months. Company insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors have recently added to or reduced their stakes in MTD. Russell Investments Group Ltd. raised its stake in Mettler-Toledo International by 29.0% during the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock valued at $137,548,000 after buying an additional 26,171 shares during the last quarter. Legato Capital Management LLC grew its holdings in shares of Mettler-Toledo International by 107.7% in the first quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock worth $2,421,000 after acquiring an additional 1,063 shares during the period. Tokio Marine Asset Management Co. Ltd. increased its position in Mettler-Toledo International by 46.7% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock valued at $9,245,000 after acquiring an additional 2,493 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 43 shares during the period. Finally, Envestnet Asset Management Inc. lifted its holdings in Mettler-Toledo International by 2.5% in the first quarter. Envestnet Asset Management Inc. now owns 15,823 shares of the medical instruments supplier’s stock valued at $18,686,000 after acquiring an additional 393 shares during the period. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.